The Hypera Pharma invested R $286.3 million, or 5.1% of your billing, in innovation throughout the third quarter of this year, record amount. From July to September the 11 launched new pharmaceutical products. Year to date, were 34 releases. The approximately 30% Hypera points out that the company's net revenue already comes from medicines launched in the last five years.
O Estado de S. Paulo - 31/10/2018
Noticia traduzida automaticamente
clique AQUI para ver a original
